ADVERTISEMENT



Google       
Call (866) 635-2689 for a free Personal Injury evaluation by attorney in your area.

Home -> Law Blog Directory -> Personal Injury Law Blogs -> Richmond Virginia Personal Injury Lawyer

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Bookmark

Personal Injury Law

: Richmond Virginia Personal Injury Lawyer

Continuous Infusion Pain Pumps Causing Cartilage Death

By Michael Phelan

ADVERTISEMENTS

Studies show a strong association between the intra-articular (inside the joint space) use of high volume pain pumps following arthroscopic shoulder surgery and an otherwise unexplainable loss of hyaline cartilage in the shoulder joint. According to a study authored by Hansen, et al. and published in the American Journal of Sports Medicine, the complication, know as PAGCL, is permanent and can lead to extreme pain and lifelong suffering in 63% of the patients who receive continuous anesthetic via a post-operative pain pump.

What is PAGCL?

PAGCL is an acronym for:

Postarthroscopic (after arthroscopic surgery)

Glenohumeral (joint of glenoid fossa + humeral head)

Chondrolysis (breakdown of cartilage cells)


Symptoms of PAGCL

The symptoms of chondrolysis are experienced over a gradual period of time, with the intitial symptoms often occurring around three to four months after the pain pump's administration. Symptoms include:

-Loss of shoulder cartilage
- Shoulder joint clicking, grinding, or popping
- Shoulder pain
- Shoulder weakness or stiffness
- Decreased range of movement
- Pain of moving at joint

Did the FDA Approve Pain Pumps for Intra-articular Use?

Continuous infusion pain pumps were not approved by the Food and Drug Administration for intra-articular use. Moreover, the manufacturers of these pumps have not published any clinical studies regarding the use of intra-articular administration of continuous infusion pain medicine. While widely used and promoted by the pump manufacturers, this form of anesthetic delivery is an off-label use and poses a serious risk to 63% of the patients on whom the device is used. In January 2009, Health Canada published a "Canadian Adverse Reaction Newsletter" urging surgeons to discontinue use of pain pumps regardless of manufacturer.


To discuss your legal rights, contact us

TOLL FREE at 866-584-2904

Originally posted at InjuryBoard by Michael Phelan

Full post as published by Richmond Virginia Personal Injury Lawyer on July 21, 2009 (boomark / email).

Bloggers, promote your law blog by nominating your blog for inclusion in USLaw.com's Law Blog Directory and RSS Reader. Benefits described.
Related Law Articles

Lawsuits and Settlements

Related Searches

























































































































US Law
#1 Online Legal Resource













Your Blog Subscriptions
Subscribe to blogs

10,000+ Law Job Listings
Lawyer . Police . Paralegal . Etc
Earn a law-related degree
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.


Practice Area
Zip Code:

Contact a Lawyer Now!






0.0024 secs (from cache 10/31/26 04:02:33)